Overview

Effect of Budesonide on Exhaled Nitric Oxide in Asthmatic Children

Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
To study the improvement in airway inflammation in children with asthma non-invasively with exhaled breath NO, a marker of inflammation, after therapy with nebulized budesonide as 0.5mg daily.
Phase:
Phase 4
Details
Lead Sponsor:
AAADRS Clinical Research Center
Collaborator:
AstraZeneca
Treatments:
Budesonide
Nitric Oxide